Abstract:Objective: To figure out the effect of somatostatin analogue Octreotide on proliferation and invasion of human hepatocellular carcinoma cell MHCC97-H and the underlying mechanism in vitro and in vivo. Methods: MHCC97-H cells were treated with Octreotide at the concentration of 0.2 ug/mL in vitro, proliferation related to time was evaluated. After treated with Octreotide at the concentration of 0.2 ug/mL for 48 h, MHCC97-H cells were observed by transmission electron microscope. Cell proliferation was detected by MTT assay after MHCC97-H cells were treated with Octreotide at different concentrations including 0.05, 0.1, 0.2, 0.4, 0.6 and 0.8 ug/mL for 36 h in vitro. 27 nude mice, in which MHCC97-H tumor mass was planted orthotopically, were divided into 3 groups randomly including control group （intraperitoneal injection with equal volume normal saline; n=8）, low dose treated group （intraperitoneal injection with Octreotide at 50 ug/kg?d; n=9） and large dose treated group （intraperitoneal injection with Octreotide at 200 ug/kg?d; n=10）. All mice were raised for 35 d and sacrificed. The information about survival time, the weight at death point and the pathology change of liver and lung was collected. The expression of vascular endothelial growth factor （VEGF） and matrix metalloproteinases-2 （MMP-2） in mouse HCC tissues were detected by immunohistochemistry finally. Results: MTT assays showed that Octreotide inhibited the proliferation of MHCC97-H cells significantly. Apoptosis cells were found by transmission electron microscope after treatment with Octreotide at 0.2 ug/mL for 48 h in vitro. The proliferation was inhibited significantly by Octreotide in a dose-dependant manner （r=0.86, P＜0.01）. Compared with control group, the treated group had the heavier weight at death point and lower intrahepatic metastasis ratio （P＜0.05）, meanwhile, there was not significant difference in treated groups （P＞0.05）. The positive expression ratios of VEGF and MMP-2 in treated groups were lower than those in control group （P＜0.05）, while there was no apparent difference in treated groups （P＞0.05）. Conclusion: Octreotide could inhibit the proliferation of MHCC97-H cells in vitro via inducing apoptosis and the inhibitory function acts in a dose-dependant manner. Octreotide could improve survival of mice with MHCC97-H cells and inhibit the metastasis of MHCC97-H cells in vivo. Regulation of VEGF and MMP-2 expression by Octreotide would be involved in its inhibition in vivo.

Inhibition Effect of Octreotide on the Growth of Gastric Carcinoma Cells SGC-7901

Inhibitory Effect of Octreotide on the Growth of Gastric Cancer in vivo and in vitro

Effect of Octreotide on the Proliferation of Esophageal Carcinona Cells Eca9706

Effect and Mechanism of Octreotide on the Viability of Gastric Cancer Cell Line SGC7901 Cells

[Inhibition of Activator Protein-1 on the Growth of Gastric Cancer by Octreotide].

Antiproliferative Effect of Octreotide on Gastric Cancer Cells Mediated by Inhibition of Akt/PKB and Telomerase.

The Effect of Octreotide on Proliferation and P-glycoprotein Expresslon of SGC-7901 Cell Line

Inhibitory Effect of Octreotide on Gastric Cancer Growth Via MAPK Pathway.

The Effect of Octreotide on Growth Inhibition of Subcutaneous Implanted Tumor with Human Gallbladder Carcinoma in Nude Mice

[Effect of siRNA for mutant p53 gene on biological behavior of gastric cancer cell line SGC7901].

Effect of octreotide on transforming growth factor-alpha in human hepatocellular carcinoma cells

Somatostatin Analog Octreotide Inhibited the Growth of Human Gastric Cancer Cell MKN45 in Vitro

Inhibition of human gastric cancer metastasis by ocreotide in vitro and in vivo]

Octreotide Inhibits Proliferation and Invasion of MHCC97-H Cells in Vitro and in Vivo

Effect of Octreotide on human hepatocellular cancer cell line MHCC97-H in vitro

Effect of Octreotide and Transforming Growth Factor-Alpha on the Proliferation of Human Hepatocellular Carcinoma Cells

The Study of Inhibition Effect of Octreotide on the Growth of Hepatocellular Carcinoma Xenografts in Situ in Nude Mice

Anti-carcinoma Effect of Targeted Radiotherapy Using 90Y-Dota-octreotide Mediated by Somatostatin Receptor

The Inhibitory Effect of Lycopene on Growth of Gastric Carcinoma Cells SGC-7901

Octreotide Inhibits Proliferation and Induces Apoptosis of Hepatocellular Carcinoma Cells.

[Inhibitory Effects of Celecoxib Combined with Octreotide on Growth of Multidrug Resistant Human Gastric Cancer Cell Line SGC7901/ADR].